Skip to content
10-Q

Quarterly Report

Dermira, Inc.

0001564590-19-016485

← back to feed
Filed
May 7, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Apr 30, 2019 53.67M sh
Capex Q1 2019 · Mar 31, 2019 $15K
Capex Q1 2019 · Mar 31, 2018 $35K
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$68.63M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$54.79M
Long Term Debt Q1 2019 · Mar 31, 2019 $32.69M
Long Term Debt Q1 2019 · Dec 31, 2018 $32.57M
Short Term Investments Q1 2019 · Mar 31, 2019 $186.14M
Short Term Investments Q1 2019 · Dec 31, 2018 $208.06M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $201.69M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $104.98M
Stockholders Equity Q1 2019 · Mar 31, 2019 $74.59M
Stockholders Equity Q1 2019 · Dec 31, 2018 −$9.04M
Stockholders Equity Q1 2019 · Mar 31, 2018 $127.87M
Stockholders Equity Q1 2019 · Dec 31, 2017 $149.65M
Current Liabilities Q1 2019 · Mar 31, 2019 $62.09M
Current Liabilities Q1 2019 · Dec 31, 2018 $38.56M
Total Liabilities Q1 2019 · Mar 31, 2019 $386.98M
Total Liabilities Q1 2019 · Dec 31, 2018 $353.36M
Current Assets Q1 2019 · Mar 31, 2019 $443.01M
Current Assets Q1 2019 · Dec 31, 2018 $335.41M
Total Assets Q1 2019 · Mar 31, 2019 $461.58M
Total Assets Q1 2019 · Dec 31, 2018 $344.32M
Sga Expense Q1 2019 · Mar 31, 2019 $48.68M
Sga Expense Q1 2019 · Mar 31, 2018 $30.51M
Rd Expense Q1 2019 · Mar 31, 2019 $15.57M
Rd Expense Q1 2019 · Mar 31, 2018 $25.59M
Net Income Q1 2019 · Mar 31, 2019 −$64.83M
Net Income Q1 2019 · Mar 31, 2018 −$59.25M
Operating Income Q1 2019 · Mar 31, 2019 −$62.72M
Operating Income Q1 2019 · Mar 31, 2018 −$56.93M
Cost Of Revenue Q1 2019 · Mar 31, 2019 $926K
Revenue Q1 2019 · Mar 31, 2019 $2.45M
Revenue Q1 2019 · Mar 31, 2018 $299K